Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Artificial Intelligence is providing astonishing results, with medicine being one of its favourite playgrounds. Machine Learning and, in particular, Deep Neural Networks are behind this revolution. Among the most challenging targets of interest in medicine are cancer diagnosis and therapies but, to start this revolution, software tools need to be adapted to cover the new requirements. In this sense, learning tools are becoming a commodity but, to be able to assist doctors on a daily basis, it is essential to fully understand how models can be interpreted. In this survey, we analyse current machine learning models and other in-silico tools as applied to medicine—specifically, to cancer research—and we discuss their interpretability, performance and the input data they are fed with. Artificial neural networks (ANN), logistic regression (LR) and support vector machines (SVM) have been observed to be the preferred models. In addition, convolutional neural networks (CNNs), supported by the rapid development of graphic processing units (GPUs) and high-performance computing (HPC) infrastructures, are gaining importance when image processing is feasible. However, the interpretability of machine learning predictions so that doctors can understand them, trust them and gain useful insights for the clinical practice is still rarely considered, which is a factor that needs to be improved to enhance doctors’ predictive capacity and achieve individualised therapies in the near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092 · cited 2×
“Sci. 2021, 22, 4394 20 of 31 with a dataset from the TCGA Program [146].”
MethodLipton, Z. C. (2018) · Queue · doi:10.1145/3236386.3241340 · Cited by 5,427
Machine Learning Applications in Cancer Prognosis and Prediction
Kourou, K., Exarchos, T. P., Exarchos, K. P., Karamouzis, M. V., & Fotiadis, D. I. (2015) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2014.11.005 · Cited by 3,338 · cited 2×
“According to a recent review [33], SVMs provide the most accurate predictions of cancer survival.”
BackgroundGreaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
Unsupervised Anomaly Detection with Generative Adversarial Networks to Guide Marker Discovery
Schlegl, T., Seeböck, P., Waldstein, S. M., Schmidt-Erfurth, U., & Langs, G. (2017) · Lecture Notes in Computer Science · doi:10.1007/978-3-319-59050-9_12 · Cited by 2,627
Combination therapy in combating cancer
Mokhtari, R. B., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B., & Yeger, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16723 · Cited by 2,543
XAI—Explainable artificial intelligence
Gunning, D., Stefik, M., Choi, J., Miller, T., Stumpf, S., & Yang, G.-Z. (2019) · Science Robotics · doi:10.1126/scirobotics.aay7120 · Cited by 2,053
Causability and explainability of artificial intelligence in medicine
Holzinger, A., Langs, G., Denk, H., Zatloukal, K., & Müller, H. (2019) · WIREs Data Mining and Knowledge Discovery · doi:10.1002/widm.1312 · Cited by 1,885 · cited 3×
“There are two aspects of unsupervised learning models relevant in the context of interpretability [39].”
BackgroundMethodInfluentialThe Cancer Genome Atlas: Creating Lasting Value beyond Its Data
Hutter, C., & Zenklusen, J. C. (2018) · Cell · doi:10.1016/j.cell.2018.03.042 · Cited by 871
Deep learning based tissue analysis predicts outcome in colorectal cancer
Bychkov, D., Linder, N., Turkki, R., Nordling, S., Kovanen, P. E., Verrill, C., Walliander, M., Lundin, M., Haglund, C., & Lundin, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-21758-3 · Cited by 644 · cited 4×
“CRC CNN, RNN Helsinki University Central Hospital Keras 420 Images Yes (Bychkov et al., 2018)”
Influential
Cited by
Chen, H., Gomez, C., Huang, C.-M., & Unberath, M. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00699-2 · Cited by 300
“Transparent ML for human experts in cancer diagnosis with AI is reviewed in [10] with a focus on 2 aspects: ML model characteristics that are important in cancer prediction and treatment; and the application of ML in cancer cases.”
BackgroundMethodBai, Q., Liu, S., Tian, Y., Xu, T., Banegas‐Luna, A. J., Pérez‐Sánchez, H., Huang, J., Liu, H., & Yao, X. (2022) · WIREs Computational Molecular Science · doi:10.1002/wcms.1581 · Cited by 156
“A new field in machine learning called Interpretable Machine Learning (IML) 27,28 or explainable artificial intelligence 29 is gaining popularity given the need to obtain additional information, be able to generalize rules from training data, and transfer those rules so that human experts from…”
BackgroundMethodSelf-citationAI and professional liability assessment in healthcare. a revolution in legal medicine?
Terranova, C., Cestonaro, C., Fava, L., & Cinquetti, A. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2023.1337335 · Cited by 73
Metadata
- Authors
- Banegas-Luna, A. J., Peña-García, J., Iftene, A., Guadagni, F., Ferroni, P., Scarpato, N., Zanzotto, F. M., Bueno-Crespo, A., & Pérez-Sánchez, H.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-04-22
- Volume
- 22
- Issue
- 9
- Pages
- 4394
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3158928250
- Cited by
- 71
- References
- 21
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey. https://app.cochat.ai/papers/10.3390/ijms22094394
- The paper
- Banegas-Luna, A. J., Peña-García, J., Iftene, A., Guadagni, F., Ferroni, P., Scarpato, N., Zanzotto, F. M., Bueno-Crespo, A., & Pérez-Sánchez, H. (2021). Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22094394
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.